These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft. Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227 [TBL] [Abstract][Full Text] [Related]
23. [Inhibition of rat heart and kidney allograft rejection by photochemical treatment of the recipient]. Oesterwitz H; Gruner S; Schneider W Z Exp Chir Transplant Kunstliche Organe; 1990; 23(4):199-201. PubMed ID: 2095643 [TBL] [Abstract][Full Text] [Related]
24. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
25. Synergistic effect of immunosuppressive drug and intrathymic inoculation of donor cells in skin graft survival. Dono K; Wood ML; Ozato H; Monaco AP Transplant Proc; 1994 Oct; 26(5):3061. PubMed ID: 7940963 [No Abstract] [Full Text] [Related]
26. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts. Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186 [TBL] [Abstract][Full Text] [Related]
27. Oral leflunomide prevents small bowel allograft rejection in the rat. He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057 [No Abstract] [Full Text] [Related]
28. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats. Lin Y; Segers C; Waer M Transplant Proc; 1996 Dec; 28(6):3036. PubMed ID: 8962178 [No Abstract] [Full Text] [Related]
29. Prolongation of allogeneic transplanted skin grafts by A85 4777, a new immunosuppressive homopiperazine derivative. Schorlemmer H; Bartlett RR; Wolf E; Seiler FR Transplant Proc; 1990 Aug; 22(4):1671-3. PubMed ID: 2389431 [No Abstract] [Full Text] [Related]
30. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts. Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572 [TBL] [Abstract][Full Text] [Related]
31. Effects of cyclosporin A in rat kidney grafts. Simms MH; Cruickshank JK; Blainey JD; Cameron AH; Barnes AD Transplant Proc; 1980 Jun; 12(2):256-60. PubMed ID: 6994293 [No Abstract] [Full Text] [Related]
32. [Effects of cyclosporin A dose on the function of the transplanted kidney. Peripheral mononuclear cells and histological findings in the transplant]. Leimenstoll G Fortschr Med; 1991 Nov; 109(32):659-60. PubMed ID: 1769633 [No Abstract] [Full Text] [Related]
33. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts. Asano T; Murai M; Nakamura H Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471 [TBL] [Abstract][Full Text] [Related]
34. Leflunomide controls rejection in hamster to rat cardiac xenografts. Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718 [TBL] [Abstract][Full Text] [Related]
35. Leflunomide immunosuppression in rat small intestinal transplantation. Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053 [No Abstract] [Full Text] [Related]
36. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone. Lin Y; Sobis H; Vandeputte M; Waer M Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959 [No Abstract] [Full Text] [Related]
37. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection. Schorlemmer HU; Kurrle R Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316 [TBL] [Abstract][Full Text] [Related]
38. Studies on FK506 in experimental organ transplantation. Ochiai T; Sakamoto K; Nagata M; Nakajima K; Goto T; Hori S; Kenmochi T; Nakagori T; Asano T; Isono K Transplant Proc; 1988 Feb; 20(1 Suppl 1):209-14. PubMed ID: 2450414 [No Abstract] [Full Text] [Related]
39. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat. Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916 [No Abstract] [Full Text] [Related]
40. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide. Lin Y; Waer M Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]